FDA Inspection 1271939 — Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings — FEI 1000526836

The FDA completed an inspection of Laboratory Corporation of America Holdings on May 23, 2025 in Raritan, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 23, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Raritan, NJ (United States)